Steve Braig, Trexel's CEO commented, "the successful completion of this transaction is consistent with Trexel's strategic objective of focusing its efforts on the accelerating growth of Trexel's MuCell molding business and will allow us to invest more aggressively in our core injection molding business." Braig noted that the divergent business models of the two companies made a spin off desirable. "Trexel's core MuCell Molding business is based completely on system sales and extensive field based applications support for a wide range of proven global injection molding applications," said Braig. "In the future, we will also focus on blow molding applications for the MuCell process within our global automotive customer base."The MuCell extrusion business," added Braig, "goes after specialized extrusion foaming applications through the use of technology licensing agreements, and we moved away from that model some time ago."